See All Slides - tctmd.com

Slides

Presentation TCT 2018

Recognition, Diagnosis, and Management of Spontaneous Coronary Artery Dissection

Presenter: Morton J. Kern, Graham Nichol, Jacqueline Saw

September 24, 2018

Presentation TCT 2018

2018 European Guidelines and Perspectives on Hypertension

Presenter: Vasilios Papademetriou, Paul A. Sobotka, Adam Witkowski

September 24, 2018

Presentation TCT 2018

Data for Lytic Therapy in Massive and Submassive Pulmonary Embolism

Presenter: Robert A. Lookstein, Akhilesh K. Sista

September 24, 2018

Presentation TCT 2018

CMS Strategy and the Move to Value

Presenter: Peter L Duffy, Timothy D. Henry, John A. Spertus

September 24, 2018

Presentation TCT 2018

Debate: Is LAA Closure a Valid Alternative for Patients With No or Mild Contraindications to Anticoagulants? No NOACs Are Strongly Preferred to LAA Closure!

Presenter: James B. Hermiller Jr, David Hildick-Smith, Freek W.A. Verheugt

September 24, 2018

Presentation TCT 2018

The Role of FFR, iFR, iMR, and WIA In Evaluating Culprit Lesion and Vessel Flow In STEMI

Presenter: Morton J. Kern, Graham Nichol, Kalpa De Silva

September 24, 2018

Presentation TCT 2018

Pro iFR!

Presenter: Jacques Monsegu

September 24, 2018

Presentation TCT 2018

Hypertension 2018 Update: From Ambulatory Monitoring to Definitional Controversies and More

Presenter: Vasilios Papademetriou, Paul A. Sobotka, Michael A. Weber

September 24, 2018

Presentation TCT 2018

Complication Lessons From the PROGRESS CTO Registry

Presenter: William L. Lombardi, Khalid Omar Tammam, Iosif Xenogiannis

September 24, 2018

Presentation TCT 2018

Acute Pulmonary Embolism: How Big Is the Problem and How to Start a PERT

Presenter: Robert A. Lookstein, Akhilesh K. Sista, Teresa L. Carman

September 24, 2018

Advertisement

Slides

Recognition, Diagnosis, and Management of Spontaneous Coronary Artery Dissection

2018 European Guidelines and Perspectives on Hypertension

Data for Lytic Therapy in Massive and Submassive Pulmonary Embolism

CMS Strategy and the Move to Value

Debate: Is LAA Closure a Valid Alternative for Patients With No or Mild Contraindications to Anticoagulants? No NOACs Are Strongly Preferred to LAA Closure!

The Role of FFR, iFR, iMR, and WIA In Evaluating Culprit Lesion and Vessel Flow In STEMI

Pro iFR!

Hypertension 2018 Update: From Ambulatory Monitoring to Definitional Controversies and More

Complication Lessons From the PROGRESS CTO Registry

Acute Pulmonary Embolism: How Big Is the Problem and How to Start a PERT

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content